Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polycyclic aromatic hydrocarbons and perinatal outcomes: a scoping review.

Pediatric research·2026
Same author

Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation.

American journal of perinatology·2026
Same author

Diagnosis and Staging of Necrotizing Enterocolitis: Current Controversies and a Phenotype-Based Framework.

Children (Basel, Switzerland)·2026
Same author

Caring for the smallest hearts: cardiovascular phenotypes and assessment in tiny babies.

Pediatric research·2026
Same author

Emerging evidence on the safety of enteral feeding during PRBC transfusion in preterm infants.

Pediatric research·2026
Same author

Point of care and plasma glucose measurements in the newborn: agreement and precision.

Pediatric research·2026

Related Experiment Video

Updated: Jul 4, 2025

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

3.6K

Do hematological biomarkers predict surgical necrotizing enterocolitis?

Srinivasan Mani1, Parvesh Mohan Garg2, Mohan Pammi3

  • 1Department of Pediatrics/Neonatology, The University of Toledo, ProMedica Russell J. Ebeid Children's Hospital, Toledo, OH, USA.

Pediatric Research
|January 31, 2024
PubMed
Summary

New research identifies gestational age-specific hematological biomarkers for necrotizing enterocolitis (NEC) in preterm infants. These findings may help predict the need for surgery and mortality, improving early diagnosis and intervention for this serious condition.

More Related Videos

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.5K
Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.2K

Related Experiment Videos

Last Updated: Jul 4, 2025

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

3.6K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.5K
Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.2K

Area of Science:

  • Neonatology
  • Pediatric Surgery
  • Gastroenterology

Background:

  • Necrotizing enterocolitis (NEC) is a critical gastrointestinal emergency in preterm infants.
  • Current diagnostic methods for NEC lack reliable early biomarkers, hindering timely intervention.
  • Hematological changes are being investigated as potential biomarkers for NEC progression and outcomes.

Purpose of the Study:

  • To identify gestational age-specific hematological biomarkers in preterm infants with NEC.
  • To determine if these biomarkers can predict the need for surgical intervention.
  • To assess the predictive value of hematological markers for mortality in NEC.

Main Methods:

  • Retrospective analysis of hematological parameters in preterm infants diagnosed with NEC.
  • Correlation of specific hematological abnormalities (e.g., thrombocytopenia, lymphopenia) and C-reactive protein levels with NEC severity and outcomes.
  • Evaluation of biomarkers based on gestational age (GA) at NEC onset.

Main Results:

  • Thrombocytopenia at NEC onset independently predicted surgical intervention in extremely preterm infants.
  • Persistent thrombocytopenia and lymphopenia at 72 hours, along with elevated C-reactive protein at 48 hours, predicted surgery in infants aged 28 to <32 weeks GA.
  • Persistent thrombocytopenia at 24 hours post-NEC onset predicted mortality in surgically treated infants.

Conclusions:

  • Gestational age-specific hematological biomarkers show promise in predicting surgical intervention and mortality in preterm infants with NEC.
  • Thrombocytopenia, lymphopenia, and C-reactive protein levels are key indicators.
  • Further prospective, multi-center studies are required to validate these findings for clinical application in early NEC diagnosis and prognostication.